Energy Health Fitness

Massive research is underway to determine how to prevent cancer.(prevent?????)

Cancer is the basis for a huge industry dominated by very large corporations that exist for the primary purpose of earning profits and creating dividends for stockholders. In the U.S. alone, cancer is a $200 billion per year industry. There are more people in the UK, Australia, Canada and the USA, earning a living from cancer than currently dying from it each year. This trend even though the cancer rate is continuing to escalate looks set to continue. The simple facts of the matter are that a lot of money is being made in the "Cancer Industry" and will continue to be made for a very long time yet.

Eliminating cancer or dramatically reducing the procedures required to treat cancer would create a very large economic loss for the "Cancer Industry" with the loss of many thousands of jobs. It is very sad to think possibly millions of lives could have been saved if proper, fully funded research was poured into cancer prevention and the education of the public, rather than pouring the money down the drain into this highly profitable, palliative care industry.

There are two main sources of funding for cancer related research in the United States. The largest is the National Cancer Institute, which distributes about $3 Billion of tax money for cancer research annually. Of this huge sum, only 2-3% is allocated to researching the prevention of cancer. The other organization funding cancer research is the American Cancer Society, which collects about $700 Million in donations annually. However, they spend virtually NOTHING on cancer prevention.

Pharmaceutical companies, which fund their own research, have ABSOLUTELY NO INCENTIVE to research cancer prevention, because all the profit potential is in treating cancer and not in preventing it. You may be shocked to learn, at the time of writing, that officers and directors of pharmaceutical companies, petrochemical companies, and tobacco companies serve as officers, board members, or directors of some of the largest cancer research organizations. Some are either current or former directors of the American Cancer Society also. From these positions of power, they are able to guide and control how cancer research money is spent.

Despite massive evidence that cancer is a metabolic disease which can be effectively treated with specialised nutritional therapy, and despite extensive documentation over many years of numerous cancer types responding extremely favourably to nutrition based protocols, there is virtually no public or private funding available for research in this area. In fact, professionals who have spoken out in presenting such information or who have advocated a nutritional approach to treating cancer patients have been ridiculed, slandered, and in some cases, even driven from their practise.

One needs to ask why?
The cancer establishment is opposed to nutrition based cancer treatment for the same reason it opposes researching cancer prevention. There is no significant money to be made with either approach. Pharmaceutical companies' motives are profit driven, and to control profits, they only market formula's they can patent. Natural ingredients, as found in nutritional products, cannot be patented so therefore any treatment involving natural products is ignored by the vested interests as it would be highly detrimental for the shareholders profits if a pharmaceutical company went down this road. Any company director who doesn't push for the maximum profits to be attained from the company operations could well find themselves being sued by shareholders. So it certainly isn't in individual directors interests to do anything else except to toe the line as far as ensuring company profits are the mandatory reason for their own existence. To protect their profitable business of making patented cancer drugs, their solution, the medical people and powerful vested interests in collusion with government departments, has been to harass anyone promoting a non-drug therapy. Government regulators and leaders of medical associations who owe much of their existence to the pharmaceutical companies fall right in line to create a united front of opposition to virtually all natural approaches to treating not just cancer, but all metabolic disease in general. To many, it borders on criminal neglect.